| [1] |
Corbett JJ, Savino PJ, Thompson HS, et al.Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss[J].Arch Neurol, 1982, 39(8): 461-474.
|
| [2] |
Best J, Silvestri G, Burton B, et al.The incidence of blindness due to idiopathic intracranial hypertension in the UK[J]. Open Ophthalmol J, 2013, 7: 26-29.
|
| [3] |
D AD, Curone M, Ciasca P, et al.Headache prevalence and clinical features in patients with idiopathic intracranial hypertension (IIH)[J]. Neurol Sci, 2013, 34(Suppl) 1: s147-149.
|
| [4] |
Radhakrishnan K, Thacker AK, Bohlaga NH, et al.Epidemiology of idiopathic intracranial hypertension: A prospective and case-control study[J]. J Neurol Sci, 1993, 116(1): 18-28.
|
| [5] |
Friedman DI.The pseudotumor cerebri syndrome[J]. Neurol Clin, 2014, 32(2): 363-396.
|
| [6] |
Quincke H. Meningitis serosa[J]. Sammlung Klinischer Vortrage Innere Medizin, 1893, 67: 655.
|
| [7] |
Nonne M. Uber Falle vom Symtomkomplex "Tumor Cerebri" mit Ausgang in Heilung "Pseudotumor Cerebri"[J]．Nervenheilkunde, 1904, 27: 169-216．
|
| [8] |
Dandy WE.intracranial pressure without brain tumor: Diagnosis and treatment[J]. Ann Surg, 1937, 106(4): 492-513.
|
| [9] |
Foley J.Benign forms of intracranial hypertension: Toxic and otitic hydrocephalus[J]. Brain, 1955, 78(1): 1-41.
|
| [10] |
Buchheit WA, Burton C, Haag B, et al.Papilledema and idiopathic intracranial hypertension[J]. N Engl J Med, 1969, 280(17): 938-942.
|
| [11] |
Smith JL. Whence pseudotumor cerebri?[J]. J Clin Neuroophthalmol, 1985, 5(1): 55-56.
|
| [12] |
Friedman DI, Jacobson DM.Diagnostic criteria for idiopathic intracranial hypertension[J]. Neurology, 2002, 59(10): 1492-1495.
|
| [13] |
Cserr HF. Role of secretion and bulk flow of brain interstitial fluid in brain volume regulation[J]. Ann N Y Acad Sci, 1988, 529: 9-20.
|
| [14] |
Iliff JJ, Wang M, Liao Y, et al.A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta[J]. Sci Transl Med, 2012, 4(147): 147ra111.
|
| [15] |
Toscano V, Sancesario G, Bianchi P, et al. Cerebrospinal fluid estrone in pseudotumor cerebri: A change in cerebral steroid hormone metabolism?[J]. J Endocrinol Invest, 1991, 14(2): 81-86.
|
| [16] |
Tomsak RL, Niffenegger AS, Remler BF. Treatment of pseudotumor cerebri with Diamox (acetazolamide)[J]. J Clin Neuroophthalmol, 1988, 18: 93-98．
|
| [17] |
Ko MW, Chang SC, Ridha MA, et al. Weight gain and recurrence in idiopathic intracranial hypertension: A case-control study[J]. Neurology, 2011, 76(18): 1564-1567.
|
| [18] |
Johnson LN, Krohel GB, Madsen RW, et al. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri)[J]. Ophthalmology, 1998,105(12): 2313-2317.
|
| [19] |
Sinclair AJ, Burdon MA, Nightingale PG, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study[J]. BMJ, 2010(341): c2701.
|
| [20] |
Farb RI, Vanek I, Scott JN, et al.Idiopathic intracranial hypertension: The prevalence and morphology of sinovenous stenosis[J]. Neurology, 2003, 60(9): 1418-1424.
|
| [21] |
King JO, Mitchell PJ, Thomson KR, et al. Cerebral venography and manometry in idiopathic intracranial hypertension[J]. Neurology, 1995, 45(12): 2224-2228.
|
| [22] |
Case D, Seinfeld J, Roark C, et al. Idiopathic intracranial hypertension: Contemporary management and endovascular techniques[J]. Semin Intervent Radiol, 2020, 37(2): 175-181.
|
| [23] |
Yri HM, Ronnback C, Wegener M, et al. The course of headache in idiopathic intracranial hypertension: A 12-month prospective follow-up study[J]. Eur J Neurol, 2014, 21(12): 1458-1464.
|
| [24] |
Karahalios DG, Rekate HL, Khayata MH, et al. Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies[J]. Neurology, 1996, 46(1): 198-202.
|
| [25] |
Huna-Baron R, Landau K, Rosenberg M, et al. Unilateral swollen disc due to increased intracranial pressure[J]. Neurology, 2001, 56(11): 1588-1590.
|
| [26] |
Wall M, George D. Idiopathic intracranial hypertension:A prospective study of 50 patients[J]. Brain, 1991, 114 (Pt 1A): 155-180.
|
| [27] |
Thambisetty M, Lavin PJ, Newman NJ, et al. Fulminant idiopathic intracranial hypertension[J]. Neurology, 2007, 68(3): 229-232.
|
| [28] |
Sadun AA, Currie JN, Lessell S.Transient visual obscurations with elevated optic discs[J]. Ann Neurol, 1984, 16(4): 489-494.
|
| [29] |
Yang IH, Pereira VM, Lenck S, et al. Endovascular treatment of debilitating tinnitus secondary to cerebral venous sinus abnormalities: A literature review and technical illustration[J].J Neurointerv Surg, 2019, 11(8): 841-846.
|
| [30] |
Sinclair AJ, Burdon MA, Nightingale PG, et al. Rating papilloedema: An evaluation of the Frisen classification in idiopathic intracranial hypertension[J]. J Neurol, 2012, 259(7): 1406-1412.
|
| [31] |
Wang JK, Kardon RH, Kupersmith MJ, et al. Automated quantification of volumetric optic disc swelling in papilledema using spectral-domain optical coherence tomography[J]. Invest Ophthalmol Vis Sci, 2012, 53(7): 4069-4075.
|
| [32] |
Piper RJ, Kalyvas AV, Young AM, et al. Interventions for idiopathic intracranial hypertension[J]. Cochrane Database Syst Rev, 2015(8): CD003434.
|
| [33] |
Newborg B. Pseudotumor cerebri treated by rice reduction diet[J].Arch Intern Med, 1974, 133(5): 802-807.
|
| [34] |
Sinclair AJ, Burdon MA, Nightingale PG, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: Prospective cohort study[J]. BMJ, 2010, 341: c2701.
|
| [35] |
Biousse V, Bruce BB, Newman NJ. Update on the pathophysiology and management of idiopathic intracranial hypertension[J].J Neurol Neurosurg Psychiatry, 2012, 83(5): 488-494.
|
| [36] |
Wall M, McDermott MP, Kieburtz KD, et al. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: The idiopathic intracranial hypertension treatment trial[J]. JAMA, 2014, 311(16): 1641-1651.
|
| [37] |
Thambisetty M, Lavin PJ, Newman NJ, et al. Fulminant idiopathic intracranial hypertension[J]. Neurology, 2007, 68(3): 229-232.
|
| [38] |
Satti SR, Leishangthem L, Chaudry MI. Meta-analysis of CSF diversion procedures and dural venous sinus stenting in the setting of medically refractory idiopathic intracranial hypertension[J]. AJNR Am J Neuroradiol, 2015, 36(10): 1899-1904.
|
| [39] |
Lee AG. Visual loss as the manifesting symptom of ventriculoperitoneal shunt malfunction[J]. Am J Ophthalmol, 1996, 122(1):127-129.
|
| [40] |
Liu GT, Volpe NJ, Schatz NJ, et al. Severe sudden visual loss caused by pseudotumor cerebri and lumboperitoneal shunt failure[J]. Am J Ophthalmol, 1996, 122(1): 129-131.
|